Tuesday, July 29, 2014 8:11:47 AM
LAS VEGAS, July 29, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (GBLX) a medical marijuana research and development company, announced that the first GrowBLOX(TM) cultivation chamber has been shipped and is expected to land in Las Vegas, Nevada, within just a few days. The timing is perfect as The Company continues to receive high interest in their cultivation science and technology. For example, The Company recently announced a binding Memorandum of Understanding with LaurelCo, LLC (Chicago, Illinois) in which GB Sciences, Inc. licensed the use of their proprietary GrowBLOXTM growing chambers in exchange for a 20% equity interest. The MOU also included licenses for additional proprietary technologies, collectively termed "GrowBLOXTM Solutions", required for tissue culture, growing chambers, curing technology, proprietary extraction processes and creation of "GBLX"-branded, pharmaceutical-grade medical marijuana products.
The GrowBLOX(TM) chamber was specifically designed to produce optimal environmental growing conditions for medical cannabis cultivation. Each chamber is equipped with the latest energy-efficient technological advancements in both lighting and hydroponic technologies—all controlled by a revolutionary intelligent control system. The GrowBLOX(TM) chamber is the first to provide real time monitoring and control of the growth process in order to consistently produce high-grade medicinal marijuana. The GrowBLOX(TM) hydroponic technology allows for continuous, healthy cycles of cannabis plants that will reach optimized medicinal potency during the bloom cycle. Each fully enclosed chamber physically isolates each plant to protect from the onset and spread of insect and mite infestations in the grow operation and to keep harmful contaminants, such as pesticides, insecticides, and vehicle exhaust out of the medicinal plants growing inside.
CEO Craig Ellins said, "Receiving the first GrowBLOX(TM) cultivation chamber is an important milestone in the history of our company. As The Company continues to pursue and develop partnerships in states with approved medical marijuana legislation, we will strongly leverage our cutting-edge cultivation technology."
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM